AP
Therapeutic Areas
AllerGene AI Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| In vivo mRNA CAR-T for Mast-Cell Driven Allergies | Severe allergic diseases and anaphylaxis | Pre-clinical |
| Drug | Indication | Phase |
|---|---|---|
| In vivo mRNA CAR-T for Mast-Cell Driven Allergies | Severe allergic diseases and anaphylaxis | Pre-clinical |